Andersen, Steen 1963-
S Andersen
Andersen, Steen
Andersen, Steen f. 1963-11-25
VIAF ID: 100520651 (Personal)
Permalink: http://viaf.org/viaf/100520651
Preferred Forms
- 100 1 _ ‡a Andersen, Steen
- 100 1 _ ‡a Andersen, Steen ‡d 1963-
-
-
- 100 0 _ ‡a S Andersen
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
Aldosterone synthase (CYP11B2)344T/C polymorphism and renoprotective response to losartan treatment in diabetic nephropathy | |
Amdi og akademisk flueknepperi | |
Angiotensin II receptor blockade in diabetic nephropathy | |
CYP2C9 variant modifies blood pressure-lowering response to losartan in Type 1 diabetic patients with nephropathy | |
Danske øjenvidner til Østfrontens gru | |
Effect of Continuous Glucose Monitoring Accuracy on Clinicians' Retrospective Decision Making in Diabetes: A Pilot Study | |
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes | |
Effect of Sensor-Augmented Pump Treatment Versus Multiple Daily Injections on Albuminuria: A 1-Year Randomized Study. | |
Evolving strategies for renoprotection: diabetic nephropathy | |
Forfatter gør op med færøske myter om det : Danske herredømme. Eller gør hun? | |
Glomerular permselectivity in early stages of overt diabetic nephropathy | |
Role of patient factors in therapy resistance to antiproteinuric intervention in nondiabetic and diabetic nephropathy | |
Sådan blev Carlsberg verdens tredjestørste bryggeri | |
Symptomkontrol i palliativ medicin : en quick guide | |
Time course of the antiproteinuric and antihypertensive effect of losartan in diabetic nephropathy | |
Treatment with continuous subcutaneous insulin infusion is associated with lower arterial stiffness. | |
Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy | |
Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy | |
Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria |